Literature DB >> 2156926

IL-6 activity in feline infectious peritonitis.

R Goitsuka1, T Ohashi, K Ono, K Yasukawa, Y Koishibara, H Fukui, Y Ohsugi, A Hasegawa.   

Abstract

Involvement of IL-6 in the development of vasculitis and polyclonal gammopathy in feline infectious peritonitis (FIP) was investigated, by using the proliferative responses of two IL-6-dependent murine hybridoma cell clones, B3B1 and MH60.BSF-2 cells. A significant IL-6 activity was found in sera and ascitic fluids of cats with FIP, whereas no IL-6 activity was detected in sera from healthy cats. In these FIP cats, IL-6 activity in ascitic fluids was significantly higher than that in sera. Peritoneal exudate cells from FIP cats were also found to release a high level of IL-6 to the culture supernatant. The ascitic IL-6 activity was eluted into the fractions corresponding to the m.w. of 30,000 to 40,000 in gel filtration, and into the fractions at the salt concentration from 0.2 to 0.3 M NaCl in anion exchange chromatography. The level of ascitic IL-6 activity was inversely correlated to serum albumin/globulin ratio in these FIP cats. These findings indicate that IL-6 accumulated in the ascites might leaked into the systemic circulation, and be linked to systemic alterations such as enhanced synthesis of Ig and acute phase proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156926

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

2.  Isolation and characterization of three subpopulations of IgG in the common cat (Felis catus).

Authors:  C I Baldwin; D A Denham
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

3.  Expression profiles of immune mediators in feline Coronavirus-infected cells and clinical samples of feline Coronavirus-positive cats.

Authors:  Nikoo Safi; Amin Haghani; Shing Wei Ng; Gayathri Thevi Selvarajah; Farina Mustaffa-Kamal; Abdul Rahman Omar
Journal:  BMC Vet Res       Date:  2017-04-07       Impact factor: 2.741

4.  Elevated interleukin 6 activity in aqueous humor of cats with uveitis.

Authors:  M R Lappin; S W Dow; J S Reif; M J Chavkin
Journal:  Vet Immunol Immunopathol       Date:  1997-08       Impact factor: 2.046

5.  TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages.

Authors:  Tomomi Takano; Tsutomu Hohdatsu; Ayako Toda; Maki Tanabe; Hiroyuki Koyama
Journal:  Virology       Date:  2007-03-23       Impact factor: 3.616

Review 6.  A review of coronavirus infection in the central nervous system of cats and mice.

Authors:  J E Foley; C Leutenegger
Journal:  J Vet Intern Med       Date:  2001 Sep-Oct       Impact factor: 3.333

7.  Whole blood cytokine profiles in cats infected by feline coronavirus and healthy non-FCoV infected specific pathogen-free cats.

Authors:  Maria E Gelain; Marina Meli; Saverio Paltrinieri
Journal:  J Feline Med Surg       Date:  2006-06-14       Impact factor: 2.015

8.  Inflammation and changes in cytokine levels in neurological feline infectious peritonitis.

Authors:  J E Foley; C Rand; C Leutenegger
Journal:  J Feline Med Surg       Date:  2003-12       Impact factor: 2.015

9.  Antibody and cytokine responses in kittens during the development of feline infectious peritonitis (FIP).

Authors:  D A Gunn-Moore; S M Caney; T J Gruffydd-Jones; C R Helps; D A Harbour
Journal:  Vet Immunol Immunopathol       Date:  1998-10-23       Impact factor: 2.046

10.  Cellular composition, coronavirus antigen expression and production of specific antibodies in lesions in feline infectious peritonitis.

Authors:  A Kipar; S Bellmann; J Kremendahl; K Köhler; M Reinacher
Journal:  Vet Immunol Immunopathol       Date:  1998-10-23       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.